Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Englewood › NPI 1083612881
Hospital

Englewood Hospital and Medical Center

Englewood Hospital and Medical Center was paid $136.90M by Medicaid between Jan 2018 and Dec 2024, across 564 billing codes. Its largest line is 93306, Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete — 6.9% of everything it billed.

33Billing provider infoENGLEWOOD HOSPITAL AND MEDICAL CENTER
ENGLEWOOD, NJ 07631
33aNPI1083612881assigned 07/14/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$136.90M
24GClaims2,749,303
24DCodes billed564
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#12 of 93
Median peer was paid$30.60M
This provider vs. median4.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018149,252$8.76M
2019201,965$11.27M
2020217,548$11.10M
2021407,451$20.55M
2022542,387$26.34M
2023655,725$31.65M
2024incomplete574,975$27.23M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 6.9% 31,652 30,317 $9.48M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 5.4% 6,996 6,625 $7.41M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.8% 27,862 25,078 $5.19M
J9271 Injection, pembrolizumab, 1 mg 3.7% 848 618 $5.01M
OP279 3.5% 25,790 23,454 $4.74M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.9% 21,414 12,917 $3.97M
93017 2.5% 20,002 18,935 $3.39M
OP278 2.4% 1,659 1,487 $3.28M
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 2.0% 13,143 12,343 $2.78M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.0% 13,462 12,772 $2.68M
80053 Comprehensive metabolic panel 1.8% 201,758 180,418 $2.51M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 8,521 7,994 $2.35M
552 more codes
99284 Emergency room visit (serious) 1.6% 10,989 $2.14M
OP710 1.5% 23,710 $2.10M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.5% 9,083 $2.07M
G0378 Hospital observation service, per hour 1.4% 3,153 $1.87M
84443 Thyroid stimulating hormone (TSH) 1.3% 86,229 $1.83M
96375 Therapeutic injection; each additional sequential IV push 1.3% 18,063 $1.73M
88305 Level IV - Surgical pathology, gross and microscopic examination 1.3% 17,846 $1.72M
80061 Lipid panel 1.1% 94,285 $1.53M
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 1.1% 2,860 $1.50M
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 203,328 $1.37M
78815 Positron emission tomography (PET) for limited area imaging <1% 1,296 $1.33M
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 12,151 $1.31M
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 3,502 $1.27M
77067 Screening mammography, bilateral, including computer-aided detection <1% 16,420 $1.22M
93970 <1% 5,260 $1.22M
93458 <1% 812 $1.13M
OP379 <1% 25,031 $1.03M
J2505 Injection, pegfilgrastim, 6 mg <1% 514 $971K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 557 $941K
J2785 Injection, regadenoson, 0.1 mg <1% 8,172 $917K
OP259 <1% 73,379 $891K
76641 <1% 11,547 $868K
A0429 Emergency ambulance ride, basic life support <1% 5,379 $837K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,727 $817K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,956 $805K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 1,052 $797K
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg <1% 486 $757K
96417 <1% 2,671 $757K
10005 <1% 2,417 $747K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 17,142 $722K
J0897 Injection, denosumab, 1 mg <1% 705 $721K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 16,398 $702K
93880 <1% 6,004 $699K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 14,780 $686K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 6,622 $685K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 10,724 $666K
93925 <1% 4,790 $661K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 2,372 $661K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 6,489 $619K
76830 Ultrasound, transvaginal <1% 5,069 $606K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 16,477 $603K
76536 <1% 6,457 $600K
93226 <1% 2,939 $591K
75574 <1% 1,274 $588K
76819 Fetal biophysical profile; without non-stress testing <1% 5,091 $558K
83036 Hemoglobin; glycosylated (A1C) <1% 69,152 $547K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,987 $526K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 2,411 $526K
70551 Magnetic resonance imaging, brain; without contrast material <1% 2,238 $509K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 2,270 $492K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 13,789 $457K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 19,785 $457K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 12,516 $448K
J1453 Injection, fosaprepitant, 1 mg <1% 1,647 $439K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 12,777 $438K
93971 <1% 2,621 $419K
96361 Intravenous infusion, hydration; each additional hour <1% 8,974 $416K
86235 <1% 3,222 $413K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,114 $400K
84439 <1% 37,096 $399K
93225 <1% 2,910 $396K
77080 <1% 6,291 $390K
86803 <1% 21,006 $387K
95806 <1% 131 $385K
59025 Fetal non-stress test <1% 2,218 $382K
A0427 Emergency ambulance ride, advanced life support <1% 2,158 $373K
77412 <1% 3,945 $368K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 13,638 $365K
C9290 Injection, bupivacaine liposome, 1 mg <1% 1,890 $365K
J1756 Injection, iron sucrose, 1 mg <1% 8,484 $359K
62323 <1% 564 $355K
70450 Computed tomography, head or brain; without contrast material <1% 6,179 $355K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 3,318 $355K
J2469 Injection, palonosetron hcl, 25 mcg <1% 3,964 $337K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 4,521 $333K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 10,610 $328K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,002 $323K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 1,576 $318K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 16,600 $316K
88173 <1% 3,465 $307K
87481 <1% 4,447 $303K
J9395 Injection, fulvestrant, 25 mg <1% 310 $291K
88312 <1% 6,982 $290K
J9045 Injection, carboplatin, 50 mg <1% 568 $290K
72197 <1% 773 $287K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 15,608 $284K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 5,190 $282K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 25,535 $280K
71046 Radiologic examination, chest; 2 views <1% 14,552 $266K
64483 <1% 252 $265K
84480 <1% 15,989 $261K
99234 <1% 1,829 $259K
74183 <1% 711 $258K
77049 <1% 749 $257K
73221 <1% 889 $246K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 9,526 $236K
82728 <1% 23,518 $236K
80048 Basic metabolic panel (calcium, ionized) <1% 37,889 $236K
83883 <1% 2,634 $232K
96411 <1% 1,202 $231K
76801 <1% 2,209 $231K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 91 $230K
77066 Tomosynthesis, mammo <1% 2,639 $216K
93978 <1% 1,460 $207K
71250 <1% 2,822 $204K
77065 Tomosynthesis, mammo <1% 4,224 $202K
81003 <1% 57,019 $201K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 10,018 $201K
87899 <1% 12,794 $200K
72141 <1% 877 $197K
81001 <1% 45,047 $190K
96376 <1% 3,073 $189K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 931 $183K
93922 <1% 2,840 $182K
86480 <1% 3,677 $179K
86003 <1% 491 $179K
72110 <1% 3,072 $172K
76770 <1% 2,359 $167K
73564 <1% 4,621 $165K
96415 <1% 1,826 $164K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 107 $161K
71275 Computed tomographic angiography, chest, with contrast material <1% 590 $160K
J9267 Injection, paclitaxel, 1 mg <1% 138 $160K
82607 <1% 13,795 $159K
96416 <1% 512 $156K
88307 <1% 1,856 $155K
88304 <1% 3,625 $152K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 5,457 $150K
82378 <1% 8,514 $147K
77091 <1% 2,554 $143K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,083 $138K
93923 <1% 1,564 $137K
96402 <1% 1,376 $135K
82043 <1% 23,672 $132K
70486 <1% 1,100 $130K
83550 <1% 25,836 $129K
86618 <1% 2,086 $129K
86769 <1% 4,950 $127K
36415 Collection of venous blood by venipuncture <1% 79,567 $127K
86300 <1% 4,143 $124K
97161 <1% 1,969 $122K
83970 <1% 4,030 $122K
76813 <1% 1,032 $122K
C1760 Closure device, vascular (implantable/insertable) <1% 1,041 $118K
87536 <1% 1,056 $116K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 457 $115K
A4648 Tissue marker, implantable, any type, each <1% 864 $115K
84146 <1% 3,850 $113K
86200 <1% 3,716 $113K
84153 <1% 6,837 $112K
88172 <1% 3,413 $111K
77336 <1% 1,682 $110K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 15,996 $109K
84402 <1% 2,506 $108K
73630 <1% 3,506 $107K
47562 <1% 95 $107K
A0425 Ground mileage, per statute mile <1% 10,564 $106K
87340 <1% 7,982 $106K
82670 <1% 2,773 $105K
88185 <1% 545 $105K
J9263 Injection, oxaliplatin, 0.5 mg <1% 126 $105K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 966 $104K
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg <1% 165 $103K
86147 <1% 1,858 $102K
A9585 Injection, gadobutrol, 0.1 ml <1% 5,825 $101K
82652 <1% 2,177 $101K
84403 <1% 2,865 $99K
83001 <1% 3,725 $97K
73130 <1% 2,728 $97K
82627 <1% 2,185 $96K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,494 $94K
71045 Radiologic examination, chest; single view <1% 8,692 $94K
C1769 Guide wire <1% 1,771 $92K
86696 <1% 2,722 $92K
86038 <1% 7,349 $91K
83540 <1% 26,633 $91K
83002 <1% 3,469 $90K
77387 <1% 2,268 $89K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 798 $86K
82746 <1% 6,688 $86K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,248 $85K
96367 <1% 3,420 $83K
86706 <1% 5,884 $82K
80076 <1% 12,125 $81K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,198 $81K
87184 <1% 6,972 $79K
87070 <1% 7,646 $79K
73030 <1% 3,107 $78K
77334 <1% 585 $78K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 11,540 $76K
74246 <1% 462 $75K
74178 <1% 212 $74K
87088 <1% 24,017 $74K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 967 $74K
86703 <1% 3,993 $74K
86140 <1% 12,874 $73K
84484 <1% 10,692 $72K
73610 <1% 2,432 $71K
82570 <1% 25,600 $69K
76981 <1% 303 $68K
C1874 Stent, coated/covered, with delivery system <1% 74 $68K
72125 Computed tomography, cervical spine; without contrast material <1% 1,535 $67K
72052 <1% 949 $67K
83690 <1% 14,712 $67K
0002A <1% 2,741 $66K
85610 <1% 18,091 $65K
83880 <1% 4,319 $65K
84425 <1% 1,789 $64K
86800 <1% 4,035 $63K
81025 <1% 7,551 $63K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 57 $62K
86431 <1% 7,735 $62K
70491 <1% 324 $61K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,123 $61K
82550 <1% 10,979 $61K
97803 <1% 1,865 $61K
0001A <1% 2,764 $61K
J0875 Injection, dalbavancin, 5 mg <1% 17 $61K
86704 <1% 4,152 $60K
87634 <1% 1,533 $58K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,688 $58K
86146 <1% 1,802 $58K
84481 <1% 3,252 $57K
80074 <1% 1,574 $57K
93976 <1% 305 $57K
93312 <1% 268 $56K
86376 <1% 4,724 $55K
83735 <1% 18,887 $55K
82784 <1% 3,476 $54K
52000 <1% 425 $53K
73110 <1% 1,520 $53K
86695 <1% 2,713 $53K
87799 <1% 477 $52K
30140 <1% 28 $52K
84550 <1% 11,004 $51K
83520 <1% 3,293 $50K
71271 <1% 709 $49K
84445 <1% 1,647 $48K
83921 <1% 2,981 $48K
87077 <1% 9,067 $48K
64493 <1% 27 $47K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 2,449 $46K
86850 <1% 7,516 $46K
83516 <1% 2,161 $45K
85730 <1% 11,421 $43K
74019 <1% 1,251 $42K
87521 Neg quan hep c or qual rna <1% 958 $41K
88184 <1% 570 $41K
86255 <1% 2,531 $40K
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units <1% 559 $40K
85652 <1% 16,177 $40K
OP229 <1% 772 $39K
83498 <1% 929 $39K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,497 $39K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 463 $39K
86735 <1% 1,621 $39K
97802 <1% 589 $39K
83615 <1% 9,394 $38K
86225 <1% 2,171 $38K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,402 $38K
82172 <1% 2,031 $37K
10022 <1% 306 $37K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 316 $37K
86039 <1% 2,355 $36K
86762 <1% 2,551 $36K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,454 $35K
72131 <1% 742 $35K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 626 $35K
83010 <1% 1,621 $35K
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg <1% 110 $34K
93975 <1% 164 $34K
86592 <1% 11,031 $33K
87506 <1% 287 $33K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 12 $32K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 13,279 $31K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg <1% 211 $29K
73502 <1% 1,845 $29K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 13,495 $29K
82533 <1% 1,923 $29K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,320 $28K
83021 <1% 1,485 $27K
82330 <1% 898 $27K
86765 <1% 2,388 $27K
87486 <1% 1,046 $27K
86787 <1% 1,308 $27K
85027 <1% 6,323 $27K
87581 <1% 1,046 $27K
83605 <1% 4,355 $26K
82962 <1% 7,138 $26K
OP258 <1% 16,741 $26K
93308 <1% 137 $25K
87430 <1% 2,144 $25K
82977 <1% 2,857 $25K
86901 <1% 7,608 $24K
94060 <1% 256 $24K
82553 <1% 4,931 $23K
87040 <1% 3,138 $23K
74174 <1% 107 $23K
86160 <1% 1,267 $23K
88187 <1% 256 $22K
86334 <1% 1,271 $21K
84702 <1% 1,748 $20K
96377 <1% 698 $20K
83525 <1% 1,545 $19K
82024 <1% 499 $19K
87517 <1% 465 $19K
86900 <1% 7,521 $19K
84100 <1% 8,890 $18K
19081 <1% 29 $18K
97162 <1% 209 $18K
84144 <1% 509 $18K
83993 <1% 507 $18K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 380 $18K
84134 <1% 1,073 $18K
85045 <1% 8,462 $17K
87512 <1% 470 $17K
76857 <1% 768 $17K
76942 <1% 293 $16K
84165 <1% 3,001 $16K
76870 <1% 243 $16K
74018 <1% 494 $15K
82157 <1% 346 $15K
C1768 Graft, vascular <1% 13 $15K
82150 <1% 1,947 $15K
J1644 Injection, heparin sodium, per 1000 units <1% 2,803 $14K
C1732 Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping <1% 17 $13K
85378 <1% 3,281 $13K
84681 <1% 595 $13K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 479 $13K
0004A <1% 531 $13K
86304 <1% 963 $12K
84154 <1% 1,142 $12K
10021 <1% 345 $12K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 474 $12K
88108 <1% 648 $12K
77300 <1% 164 $12K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 30 $11K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 676 $11K
82985 <1% 1,619 $11K
C9600 Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch <1% 35 $11K
82397 <1% 454 $11K
82105 <1% 739 $10K
99213 Doctor's office visit, returning patient (routine) <1% 273 $10K
86361 <1% 472 $10K
87081 <1% 1,072 $10K
83721 <1% 1,757 $9K
82274 <1% 1,146 $9K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,643 $9K
94760 <1% 1,219 $9K
88142 <1% 256 $9K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 127 $9K
73080 <1% 306 $9K
82166 <1% 235 $9K
84478 <1% 1,011 $9K
70498 <1% 43 $8K
72100 <1% 255 $8K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 811 $8K
86021 <1% 197 $8K
84432 <1% 468 $8K
86256 <1% 559 $8K
0011A <1% 362 $8K
82232 <1% 843 $8K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,299 $8K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 245 $8K
90715 <1% 490 $8K
82247 <1% 2,302 $8K
80320 <1% 1,166 $7K
36591 <1% 237 $7K
0012A <1% 263 $7K
94729 <1% 377 $7K
84630 <1% 466 $7K
84305 <1% 295 $7K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 58 $7K
72170 <1% 352 $7K
96523 <1% 210 $7K
88313 <1% 238 $7K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 105 $7K
86364 <1% 565 $7K
93351 <1% 39 $7K
J9190 Injection, fluorouracil, 500 mg <1% 853 $7K
90870 <1% 38 $6K
80050 General health panel <1% 176 $6K
96368 <1% 57 $6K
87529 <1% 102 $6K
87338 <1% 680 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 297 $6K
76000 <1% 693 $6K
83695 <1% 662 $6K
84460 <1% 1,693 $6K
84450 <1% 1,664 $5K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 47 $5K
82465 <1% 1,017 $5K
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units <1% 335 $5K
78306 <1% 79 $5K
88311 <1% 762 $5K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 28 $5K
84703 <1% 714 $5K
82947 <1% 1,332 $5K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,880 $5K
86430 <1% 782 $5K
86481 <1% 86 $5K
82088 <1% 120 $5K
93798 <1% 230 $5K
0003A <1% 213 $5K
76775 <1% 103 $5K
72070 <1% 117 $5K
88342 <1% 131 $4K
86340 <1% 183 $4K
81490 <1% 12 $4K
84166 <1% 289 $4K
82565 <1% 856 $4K
80299 <1% 488 $4K
80143 <1% 428 $4K
82785 <1% 236 $4K
80179 <1% 784 $4K
77280 <1% 58 $4K
29125 <1% 67 $4K
75635 <1% 40 $4K
97165 <1% 99 $4K
93990 <1% 25 $4K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 6,819 $4K
87147 <1% 742 $3K
77003 <1% 947 $3K
84156 <1% 1,291 $3K
82787 <1% 55 $3K
77417 <1% 172 $3K
73140 <1% 118 $3K
73718 <1% 15 $3K
12001 <1% 25 $3K
C1730 Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) <1% 19 $3K
87625 <1% 302 $3K
0064A <1% 114 $3K
93926 <1% 44 $3K
84520 <1% 664 $3K
82950 <1% 775 $3K
85613 <1% 231 $3K
0071A <1% 105 $3K
80177 <1% 124 $3K
87209 <1% 291 $3K
86341 <1% 39 $3K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 47 $3K
84244 <1% 90 $3K
86335 <1% 106 $2K
74240 <1% 12 $2K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 21 $2K
0124A <1% 120 $2K
88341 <1% 31 $2K
88302 <1% 116 $2K
0072A <1% 92 $2K
86708 <1% 125 $2K
81050 <1% 402 $2K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 16 $2K
29515 <1% 40 $2K
87324 <1% 642 $2K
73590 <1% 90 $2K
74220 <1% 95 $2K
74021 <1% 66 $2K
73560 <1% 81 $2K
84436 <1% 473 $2K
87177 <1% 291 $2K
82656 <1% 106 $2K
86148 <1% 96 $2K
71100 <1% 68 $2K
85041 <1% 1,498 $1K
86617 <1% 28 $1K
85384 <1% 170 $1K
96409 <1% 29 $1K
85014 <1% 1,703 $1K
84235 <1% 32 $1K
J0640 Injection, leucovorin calcium, per 50 mg <1% 37 $1K
73700 <1% 13 $1K
OP276 <1% 28 $1K
85018 <1% 1,621 $1K
82164 <1% 45 $1K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 1,681 $1K
83835 <1% 100 $1K
70480 <1% 14 $1K
83519 <1% 29 $1K
84270 <1% 51 $1K
72050 <1% 15 $1K
94726 <1% 70 $1K
93613 <1% 17 $1K
86329 <1% 81 $1K
80069 <1% 243 $1K
94727 <1% 61 $1K
86774 <1% 72 $955.47
86709 <1% 62 $951.46
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 1,256 $945.10
82248 <1% 117 $936.55
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,059 $928.88
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 46 $926.64
P9016 Red blood cells, leukocytes reduced, each unit <1% 13 $924.76
84590 <1% 55 $863.11
84482 <1% 29 $863.07
87420 <1% 60 $848.41
85303 <1% 42 $842.57
J1741 Injection, ibuprofen, 100 mg <1% 73 $817.32
87563 <1% 45 $806.23
36430 <1% 14 $786.34
83704 <1% 30 $785.89
A9581 Injection, gadoxetate disodium, 1 ml <1% 30 $782.87
76098 <1% 55 $761.96
87045 <1% 78 $703.26
72082 <1% 13 $608.34
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries <1% 76 $553.70
82085 <1% 39 $525.04
J2060 Injection, lorazepam, 2 mg <1% 367 $523.09
86780 <1% 37 $504.87
87205 <1% 71 $496.16
82668 <1% 55 $492.69
75571 <1% 338 $477.94
82310 <1% 111 $413.75
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 32 $397.77
80164 <1% 54 $392.25
36416 <1% 169 $350.54
87046 <1% 91 $350.10
85576 <1% 16 $333.45
87075 <1% 64 $302.65
84132 <1% 275 $289.96
86615 <1% 13 $279.36
88300 <1% 32 $263.18
82040 <1% 646 $246.56
85300 <1% 15 $233.52
86705 <1% 15 $232.08
87185 <1% 48 $169.86
J3360 Injection, diazepam, up to 5 mg <1% 12 $154.50
87341 <1% 13 $146.28
82803 <1% 15 $143.16
86593 <1% 28 $137.53
77081 <1% 13 $127.96
0054A <1% 14 $125.63
83655 <1% 13 $121.24
82270 <1% 132 $117.21
86308 <1% 14 $116.63
81015 <1% 1,845 $104.68
97116 <1% 17 $99.66
83020 <1% 13 $85.33
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 601 $77.87
84157 <1% 15 $77.17
84300 <1% 26 $71.77
84479 <1% 595 $65.73
82542 <1% 12 $64.99
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 76 $55.58
86922 <1% 14 $43.96
82340 <1% 12 $27.97
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 109 $20.53
J3490 Unclassified drugs <1% 22 $9.30
64494 <1% 27 $7.00
84295 <1% 16 $6.70
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) <1% 30 $6.00
J0360 Injection, hydralazine hcl, up to 20 mg <1% 17 $5.24
J0670 Injection, mepivacaine hydrochloride, per 10 ml <1% 13 $3.57

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDUCHAK, DOUGLAS (CEO)